Basic Avana Information

• INN (International Nonproprietary Name): Avanafil
• Brand Names Available In Australia: Spedra (50 mg, 100 mg, 200 mg tablets in foil blisters)
• ATC Code: G04BE11
• Forms & Dosages: Oral tablets — 50 mg, 100 mg, 200 mg
• Manufacturers In Australia: Menarini Group distributes Spedra in Australia
• Registration Status In Australia: Spedra is registered/approved and sold in Australia (branded product)
• OTC / Rx Classification: Prescription Only (Rx)

Latest Research Highlights

Patients often ask if avanafil is backed by recent studies and safety monitoring.

Randomised trials and post‑marketing surveillance from 2022–2025 continue to support avanafil as an effective, rapid‑onset PDE5 inhibitor.

Time‑to‑onset is a key feature, with 100 mg demonstrating onset as fast as about 15 minutes in trial settings.

Safety profiles remain similar or slightly favourable compared with older PDE5 inhibitors due to less PDE6 cross‑reactivity and fewer visual disturbances.

Regulatory milestones include FDA approval as Stendra in 2012 and EMA approval as Spedra in 2013, with ongoing pharmacovigilance via the TGA in Australia.

Australian small observational cohorts (2022–24) mirror international efficacy and safety outcomes but note potential under‑reporting from rural and remote health services.

Safety signals from 2022–25 emphasise hypotension when used with nitrates and with potent CYP3A4 inhibitors, and isolated, rare reports of priapism.

Clinical takeaway: avanafil is a useful fast‑onset option for men wanting a quick‑acting on‑demand ED pill, while clinicians should remain cautious in people with multiple comorbidities and complex drug regimens.

Clinical Effectiveness In Australia

Clinicians commonly ask how Spedra performs in the Australian real‑world setting.

Spedra is marketed in Australia in 50 mg, 100 mg and 200 mg blister packs and is prescription‑only.

Australian TGA reports and clinic audits show effectiveness comparable with international trials, with improved erectile function scores and strong patient satisfaction when dosing and timing are correct.

Many patients report best effect with 100 mg taken about 15 minutes before activity.

Effectiveness is moderated by common Australian comorbidities such as type 2 diabetes and cardiovascular disease.

Socioeconomic factors affect adherence, with privately paying patients reporting lower long‑term adherence than those with easier access to subsidised care.

Practical note for prescribers: screen for concurrent nitrates, cardiovascular instability and review any CYP3A4 inhibitors before prescribing Spedra.

Indications And Expanded Uses

People often wonder if avanafil is used for anything outside erectile dysfunction.

Approved indications across TGA, EMA and FDA are for the treatment of erectile dysfunction using on‑demand dosing only.

Avanafil is not indicated for women or children.

Off‑label use in Australia is rare and generally discouraged unless in specialist settings with informed consent.

There is no approval for pulmonary arterial hypertension, Raynaud’s or lower urinary tract symptoms for avanafil, unlike some other PDE inhibitors.

Some urology centres may trial avanafil for specific ED subgroups, such as post‑radical prostatectomy patients, but evidence is limited and often single‑centre.

Regulatory note: Spedra is prescription‑only and clinician assessment is required before use.

Document informed consent and consult TGA guidance if considering off‑label prescribing.

Composition And Brand Landscape

People shopping for avana often ask which brands and strengths are available locally.

The active ingredient is avanafil (INN).

Key global brands are Spedra® in Europe, the United Kingdom and Australia, and Stendra® in the United States and Canada.

Available tablet strengths are 50 mg, 100 mg and 200 mg, typically in foil blister packs labelled with product and dose.

Menarini Group distributes Spedra in Europe and Australia, while Vivus Inc. owns Stendra in the US market.

As of August 2025 there are no widely available generics reported in the supplied data.

Pharmacists should check the Consumer Medicines Information and the TGA ARTG entry for product‑specific excipients or allergen notes before dispensing.

Commercially, brand recognition and cost sensitivity affect dispensing choices, and many customers compare Spedra prices across major chains and online services.

Contraindications And Special Precautions

Safety is the top concern for many people considering Spedra.

Absolute contraindications include concurrent nitrates, use with guanylate cyclase stimulators such as riociguat, known hypersensitivity to avanafil or excipients, severe cardiovascular instability, recent myocardial infarction or stroke, unstable angina, and severe hepatic impairment.

Relative cautions include anatomical penile deformities, states that predispose to priapism, severe renal impairment, recent cardiac events, active arrhythmias, poorly controlled blood pressure, and retinitis pigmentosa.

In Australia clinicians should note that older adults commonly have polypharmacy, including CYP3A4 inhibitors, and Indigenous populations have higher baseline cardiovascular and diabetes risks requiring careful screening.

Advise against heavy alcohol use with avanafil because of possible orthostatic hypotension and impaired judgement affecting driving and work safety.

• Absolute Contraindications: Nitrates, riociguat, hypersensitivity, severe cardiovascular instability, severe hepatic impairment.
• Cautions: Priapism risk states, severe renal impairment, penile deformities, retinitis pigmentosa.

Prescribers can use a simple decision flow: screen for nitrates and riociguat → assess cardiovascular stability → review drug interactions (CYP3A4) → choose dose or decline if contraindicated.

Dosage Guidelines

Common patient questions are about how much and when to take Spedra.

Standard on‑demand regimen: tablets available in 50 mg, 100 mg and 200 mg, with 100 mg as the typical starting dose.

Timing guidance: 100 mg is typically taken about 15 minutes before sexual activity and may be taken with or without food.

50 mg may be used for conservatism or when interactions are present and is usually taken about 30 minutes before activity.

200 mg is reserved for patients who do not achieve an adequate response or who tolerate lower doses well.

Frequency: take a single dose per sexual occasion; not intended for daily chronic dosing.

Adjustments: no routine initial elderly dose change but monitor tolerability; mild/moderate renal impairment usually needs no change; severe renal impairment use caution; mild/moderate hepatic impairment use a lower dose and avoid in severe hepatic impairment.

Counselling checklist: try the dose at home first, avoid heavy alcohol, report any sudden vision changes, chest pain, or prolonged erection over four hours.

Interactions Overview

Drug interactions are a frequent concern and must be checked before dispensing.

Absolute interaction risks include nitrates and guanylate cyclase stimulators such as riociguat, both of which may cause life‑threatening hypotension when combined with avanafil.

Strong CYP3A4 inhibitors such as ritonavir and ketoconazole can increase avanafil exposure and may require dose reduction or avoidance of higher strengths.

Potent CYP3A4 inducers may lower effectiveness of avanafil.

Alpha‑blockers carry an additive hypotension risk; stagger dosing and start alpha‑blockers at low dose under supervision if required.

Food has minimal effect, but a large fatty meal may delay onset, and alcohol increases orthostatic hypotension risk.

Counselling prompt: always ask about prescription medicines, OTCs, herbal remedies such as St John’s wort and recreational drugs before supplying Spedra.

Cultural Perceptions And Patient Habits In Australia

Many Australian men prefer telehealth and discreet pharmacy options when seeking ED treatment.

Price sensitivity is common, and patients often compare branded Spedra with cheaper sildenafil or tadalafil generics when cost is a factor.

Urban patients report easier access and greater willingness to discuss ED with clinicians and pharmacists than rural or remote patients.

Stigma remains among older men and in some Indigenous communities, so culturally safe approaches and liaison with Aboriginal Medical Services are important.

Pharmacists are a trusted source of information and many patients expect practical, confidential advice before obtaining a private prescription.

Telehealth services and online pharmacies have expanded access, but continuity of care and accurate medication records must be maintained.

• Access Pathways: GP consult, telehealth prescription, pharmacist‑supported referral or specialist urology clinic.
• Rural Solutions: Mail‑order dispensing or liaising with local community health services to manage lead times and supply.

Availability And Pricing Patterns In Australia

Patients commonly ask whether Spedra is subsidised on the PBS and where to buy it.

In the supplied data there is no clear evidence that avanafil is PBS‑listed, and Spedra is generally dispensed as a private prescription in Australia.

Spedra is available in major pharmacy chains, independent community pharmacies and through online or telehealth services as the branded product in 50 mg, 100 mg and 200 mg blister packs.

Prices vary between brick‑and‑mortar pharmacies and online telepharmacies, and many shoppers compare major chains for best private price.

Rural and remote patients should be advised about possible lead times and that mail‑order delivery may be the most reliable supply route.

For cost‑sensitive consumers, consider clinically appropriate alternatives such as sildenafil or tadalafil generics where suitable.

Purchase context: In our online pharmacy, avana is available without a prescription, with discreet delivery to Australia in 5–14 days.

Comparable Medicines And Preferences

Choosing between PDE5 inhibitors depends on onset, duration, cost and side‑effect profile.

Sildenafil is widely available generically and is generally cheaper but usually has a slower onset and greater PDE6 activity than avanafil.

Tadalafil offers the longest duration of action (up to 36 hours) and a daily dosing option for frequent sexual activity.

Vardenafil has a similar onset to sildenafil but may cause more visual disturbances for some men.

Clinical preference drivers in Australia include desire for quick onset (favouring avanafil), need for a long‑acting option (favouring tadalafil), and cost considerations (favouring sildenafil generics).

FAQ — Common Australian Patient Questions

1. How Quickly Does It Work? — A 100 mg dose may act in about 15 minutes for some men, though individual response varies.
2. Can I Take It With Alcohol? — Small amounts are generally tolerated but heavy drinking increases dizziness and hypotension risk; avoid driving if affected.
3. Is It On The PBS? — The supplied data does not confirm PBS listing and most prescriptions are private; check current PBS listings and ask your pharmacist.
4. What If I’m On Heart Medication? — Do not take avanafil with nitrates or riociguat; review all cardiac medicines and CYP3A4 inhibitors with your prescriber or pharmacist.

Signpost: if you experience severe adverse effects report them to the TGA and seek urgent care for chest pain or an erection lasting more than four hours.

Guidelines For Proper Use — Pharmacy Counselling And Patient Advice

Pharmacists play a key role in safe avanafil use and patient education.

Confirm the indication is erectile dysfunction and that the prescription is appropriate for on‑demand use only.

Review cardiovascular history and specifically ask about nitrates and riociguat.

Check for CYP3A4 inhibitors and alpha‑blockers and advise dose adjustments or alternative therapy as required.

Explain timing: 100 mg about 15 minutes before activity, 50 mg about 30 minutes if preferred, and 200 mg only if lower doses fail and tolerability is confirmed.

Advise on alcohol, driving safety, and the signs that require urgent medical attention such as chest pain or priapism.

Provide the Consumer Medicines Information and advise patients to report suspected adverse reactions to the TGA.

Telehealth tips: verify e‑prescription authenticity, counsel on storage at 20–25°C in the original blister pack and arrange follow‑up with the patient’s GP for continuity.

For rural and Indigenous patients use culturally appropriate language, involve local health services and allow extra lead time for mail‑order supply.

• Pharmacist Counselling Script (Short): Confirm heart meds and nitrates → Check other medicines → Recommend starting dose and timing → Warn about alcohol and safety → Provide CMI and TGA reporting info.
• Red Flags To Tell Patients: Chest pain, sudden vision loss, severe dizziness, erection >4 hours.

Delivery Across Australia